BACE1 and Alzheimer disease: Together, this suggests that the impact of the TFLA, probiotic or synbiotic interventions is more pronounced in the APP-BACE1 AD group compared to the control elav-Gal4 aging group suggesting that the differences in survivability is not only reflecting normal aging (S1 Fig).